Most Profitable Drug Manufacturers - Specialty & Generic Companies
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Income
Net Income | Efficiency | Market Risk | Exp Return | ||||
---|---|---|---|---|---|---|---|
1 | LNTH | Lantheus Holdings | (0.06) | 3.68 | (0.22) | ||
2 | KALY | Kali Inc | 0.00 | 0.00 | 0.00 | ||
3 | NSRS | North Springs Resources | 0.00 | 0.00 | 0.00 | ||
4 | KGET | Kleangas Energy Tech | 0.00 | 0.00 | 0.00 | ||
5 | SXTC | China SXT Pharmaceuticals | (0.16) | 6.53 | (1.02) | ||
6 | GELS | Gelteq Limited Ordinary | (0.20) | 9.40 | (1.87) | ||
7 | RMTI | Rockwell Medical | (0.03) | 7.03 | (0.20) | ||
8 | BIOA | BioAge Labs, | 0.05 | 5.51 | 0.25 | ||
9 | YCBD-PA | cbdMD Inc | 0.09 | 4.75 | 0.43 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.